Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Identification and Characterization of Preferred DNA-Binding Sites for the Thermus thermophilus HB8 Transcriptional Regulator TTHA0973.

Cox JS, Moncja K, Mckinnes M, Van Dyke MW.

Int J Mol Sci. 2019 Jul 7;20(13). pii: E3336. doi: 10.3390/ijms20133336.

2.

Identification and characterization of preferred DNA-binding sites for the Thermus thermophilus transcriptional regulator FadR.

Lee M, Um H, Van Dyke MW.

PLoS One. 2017 Sep 13;12(9):e0184796. doi: 10.1371/journal.pone.0184796. eCollection 2017.

3.

Identification of Preferred DNA-Binding Sites for the Thermus thermophilus Transcriptional Regulator SbtR by the Combinatorial Approach REPSA.

Van Dyke MW, Beyer MD, Clay E, Hiam KJ, McMurry JL, Xie Y.

PLoS One. 2016 Jul 18;11(7):e0159408. doi: 10.1371/journal.pone.0159408. eCollection 2016.

4.

Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.

Van Dyke MW.

ChemMedChem. 2014 Mar;9(3):511-22. doi: 10.1002/cmdc.201300444. Epub 2014 Jan 21. Review.

5.

Triple helix-interacting proteins and cancer.

Van Dyke M, Nelson L.

OA Mol Oncol. 2013 Apr 1;1(1):5.

6.

The Saccharomyces cerevisiae protein Stm1p facilitates ribosome preservation during quiescence.

Van Dyke N, Chanchorn E, Van Dyke MW.

Biochem Biophys Res Commun. 2013 Jan 11;430(2):745-50. doi: 10.1016/j.bbrc.2012.11.078. Epub 2012 Dec 1.

PMID:
23206692
7.

Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer.

Nelson LD, Bender C, Mannsperger H, Buergy D, Kambakamba P, Mudduluru G, Korf U, Hughes D, Van Dyke MW, Allgayer H.

Mol Cancer. 2012 Jun 8;11:38. doi: 10.1186/1476-4598-11-38.

8.

Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16.

Pickering BF, Yu D, Van Dyke MW.

J Biol Chem. 2011 Dec 23;286(51):44095-103. doi: 10.1074/jbc.M111.265439. Epub 2011 Nov 2.

9.

Molecular mechanism by which the nucleoid occlusion factor, SlmA, keeps cytokinesis in check.

Tonthat NK, Arold ST, Pickering BF, Van Dyke MW, Liang S, Lu Y, Beuria TK, Margolin W, Schumacher MA.

EMBO J. 2011 Jan 5;30(1):154-64. doi: 10.1038/emboj.2010.288. Epub 2010 Nov 26.

10.

REPSA: combinatorial approach for identifying preferred drug-DNA binding sequences.

Van Dyke MW.

Methods Mol Biol. 2010;613:193-205. doi: 10.1007/978-1-60327-418-0_12.

PMID:
19997885
11.

Stm1p alters the ribosome association of eukaryotic elongation factor 3 and affects translation elongation.

Van Dyke N, Pickering BF, Van Dyke MW.

Nucleic Acids Res. 2009 Oct;37(18):6116-25. doi: 10.1093/nar/gkp645. Epub 2009 Aug 7.

12.

Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions.

Gopal YN, Chanchorn E, Van Dyke MW.

Mol Cancer Ther. 2009 Mar;8(3):552-62. doi: 10.1158/1535-7163.MCT-08-0661. Epub 2009 Mar 10.

13.
14.

Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.

Baby J, Pickering BF, Vashisht Gopal YN, Van Dyke MW.

Cancer Lett. 2007 Sep 18;255(1):85-94. Epub 2007 May 9.

PMID:
17493745
15.

REPSA: general combinatorial approach for identifying preferred ligand-DNA binding sequences.

Van Dyke MW, Van Dyke N, Sunavala-Dossabhoy G.

Methods. 2007 Jun;42(2):118-27. Review.

PMID:
17472894
16.

Depletion of histone deacetylase protein: a common consequence of inflammatory cytokine signaling?

Gopal YN, Van Dyke MW.

Cell Cycle. 2006 Dec;5(23):2738-43. Epub 2006 Dec 1.

PMID:
17172847
17.

Stm1p, a ribosome-associated protein, is important for protein synthesis in Saccharomyces cerevisiae under nutritional stress conditions.

Van Dyke N, Baby J, Van Dyke MW.

J Mol Biol. 2006 May 12;358(4):1023-31. Epub 2006 Mar 24.

PMID:
16580682
18.

Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2.

Vashisht Gopal YN, Arora TS, Van Dyke MW.

EMBO Rep. 2006 Mar;7(3):291-6. Epub 2005 Dec 23.

19.

Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.

Sunavala-Dossabhoy G, Van Dyke MW.

Biochemistry. 2005 Feb 22;44(7):2510-22.

PMID:
15709763
20.

Stm1p, a G4 quadruplex and purine motif triplex nucleic acid-binding protein, interacts with ribosomes and subtelomeric Y' DNA in Saccharomyces cerevisiae.

Van Dyke MW, Nelson LD, Weilbaecher RG, Mehta DV.

J Biol Chem. 2004 Jun 4;279(23):24323-33. Epub 2004 Mar 23.

21.

Combinatorial determination of sequence specificity for nanomolar DNA-binding hairpin polyamides.

Vashisht Gopal YN, Van Dyke MW.

Biochemistry. 2003 Jun 10;42(22):6891-903.

PMID:
12779344
22.

Identification of preferred actinomycin-DNA binding sites by the combinatorial method REPSA.

Shen J, Wang JC, Van Dyke MW.

Bioorg Med Chem. 2001 Sep;9(9):2285-93.

PMID:
11553467
23.

Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin.

Ciotti P, Van Dyke MW, Bianchi-ScarrĂ  G, Musso M.

Eur J Biochem. 2001 Jan;268(2):225-34.

24.

The yeast CDP1 gene encodes a triple-helical DNA-binding protein.

Musso M, Bianchi-ScarrĂ  G, Van Dyke MW.

Nucleic Acids Res. 2000 Nov 1;28(21):4090-6.

25.

The yeast STM1 gene encodes a purine motif triple helical DNA-binding protein.

Nelson LD, Musso M, Van Dyke MW.

J Biol Chem. 2000 Feb 25;275(8):5573-81.

26.

Differential effects of cyclopolyamines on the stability and conformation of triplex DNA.

Antony T, Musso M, Hosseini MW, Brand G, Greenfield NJ, Thomas T, Van Dyke MW, Thomas TJ.

Antisense Nucleic Acid Drug Dev. 1999 Feb;9(1):13-23.

PMID:
10192285
27.

Self-association of G-rich oligodeoxyribonucleotides under conditions promoting purine-motif triplex formation.

Cheng AJ, Wang JC, Van Dyke MW.

Antisense Nucleic Acid Drug Dev. 1998 Jun;8(3):215-25.

PMID:
9669659
28.

Plasmids for the in vitro analysis of RNA polymerase II-dependent transcription based on a G-free template.

Wang JC, Sawadogo M, Van Dyke MW.

Biochim Biophys Acta. 1998 Apr 29;1397(2):141-5.

PMID:
9565670
29.

Multiple rounds of transcription by RNA polymerase II at covalently cross-linked templates.

Szentirmay MN, Musso M, Van Dyke MW, Sawadogo M.

Nucleic Acids Res. 1998 Jun 1;26(11):2754-60.

30.

Characterization of purine-motif triplex DNA-binding proteins in HeLa extracts.

Musso M, Nelson LD, Van Dyke MW.

Biochemistry. 1998 Mar 3;37(9):3086-95.

PMID:
9485462
31.

Identification of preferred distamycin-DNA binding sites by the combinatorial method REPSA.

Hardenbol P, Wang JC, Van Dyke MW.

Bioconjug Chem. 1997 Sep-Oct;8(5):617-20.

PMID:
9327123
32.
33.

Identification of preferred hTBP DNA binding sites by the combinatorial method REPSA.

Hardenbol P, Wang JC, Van Dyke MW.

Nucleic Acids Res. 1997 Aug 15;25(16):3339-44.

34.
35.

In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides.

Musso M, Wang JC, Van Dyke MW.

Nucleic Acids Res. 1996 Dec 15;24(24):4924-32.

36.

Regional back pain: you've got it, you're my patient.

Van Dyke MW.

J Occup Environ Med. 1996 Oct;38(10):979-80. No abstract available.

PMID:
8899573
38.

Torsionally-strained DNA and intermolecular purine-purine-pyrimidine triple-helix formation.

Musso M, Van Dyke MW.

Mol Cell Biochem. 1996 Jan 12;154(1):65-70.

PMID:
8717418
40.

Indirect use of immobilized metal affinity chromatography for isolation and characterization of protein partners.

Sawadogo M, Van Dyke MW.

Genet Eng (N Y). 1995;17:53-65. Review. No abstract available.

PMID:
7540027
41.
42.

Sp1, USF, and GAL4 activate transcription independently of TFIID-downstream promoter interactions.

Wang JC, Van Dyke MW.

Biochim Biophys Acta. 1994 Aug 2;1218(3):308-14.

PMID:
8049256
43.
44.

Initiator sequences direct downstream promoter binding by human transcription factor IID.

Wang JC, Van Dyke MW.

Biochim Biophys Acta. 1993 Oct 19;1216(1):73-80.

PMID:
8218418
45.

An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2.

Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW, Tainsky MA.

Mol Cell Biol. 1993 Jul;13(7):4174-85.

46.

In vitro inhibition of c-myc transcription by mithramycin.

Hardenbol P, Van Dyke MW.

Biochem Biophys Res Commun. 1992 Jun 15;185(2):553-8.

PMID:
1535193
47.

Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain.

Van Dyke MW, Sirito M, Sawadogo M.

Gene. 1992 Feb 1;111(1):99-104.

PMID:
1547959
48.

A rapid method for the purification of deprotected oligodeoxynucleotides.

Sawadogo M, Van Dyke MW.

Nucleic Acids Res. 1991 Feb 11;19(3):674. No abstract available.

49.

Aggressive early medical management.

Van Dyke MW.

J Occup Med. 1990 Oct;32(10):966. No abstract available.

PMID:
2262826
50.

Supplemental Content

Loading ...
Support Center